Lung Cancer

November 3, 2017November 3, 2017

Real-World Study Confirms Benefits of Percepta Genomic Classifier in Diagnosing Lung Cancer

Lung Cancer, News

Real-world clinical data has shown that the Percepta Bronchial Genomic Classifier can help identify patients with a low risk of lung cancer, significantly reducing the need for invasive, risky, and expensive ... Read more

November 2, 2017November 2, 2017

Experts Release New Guidelines for Lung Cancer Screening at CHEST 2017

Lung Cancer, News

In a manuscript published in the journal CHEST, a group of experts discuss recent evidence concerning the benefit, harms, and implementation of low-radiation dose chest computed tomography (CT) in lung cancer screening. ... Read more

October 19, 2017October 19, 2017

FDA Giving Priority Review to Gilotriftm as Treatment for Rare Form of Lung Cancer

Lung Cancer, News

The U.S. Food and Drug Administration is giving priority review to Boehringer Ingelheim’s request that the agency consider approving Gilotriftm (afatinib) for an additional category of lung cancer patients. Gilotriftm is already approved ... Read more

October 17, 2017October 17, 2017

Opdivo, Alone or Combined with Yervoy, Extends Lung Cancer Patients’ Survival, Phase 1/2 Trial Shows

Lung Cancer, News

Opdivo (nivolumab) has shown promise as a treatment for recurring small lung cancer patients who have a lot of genetic errors in their tumors, according to a Phase 1/2 clinical trial. ... Read more

October 4, 2017October 4, 2017

Europe Approves Tecentriq Therapy for Advanced or Metastatic NSCLC

Lung Cancer, News

Patients in the European Union who have advanced or metastatic non-small cell lung cancer (NSCLC) now can be treated with Roche’s Tecentriq (atezolizumab). According to the European Commission marketing authorization, ... Read more

September 22, 2017September 22, 2017

Veracyte, LCI Aim to Raise Awareness in N.C. About Early Lung Cancer Screening

Lung Cancer, News

In partnership with the Lung Cancer Initiative (LCI), Veracyte has launched an awareness-raising campaign to increase screening for lung cancer among high-risk populations in North Carolina. The campaign, “Screen Together,” was created to ... Read more

September 18, 2017September 18, 2017

AstraZeneca’s Tagrisso a Potential New Standard of Care in EGFR-mutated Lung Cancer

Lung Cancer, News

Results of a Phase 3 trial support the use of Tagrisso (osimertinib) as a new standard of care in the first-line treatment of patients with epidermal growth factor receptor-mutated (EGFRm) ... Read more

August 25, 2017August 25, 2017

E-Cigarettes Carry Much Less Risk of Lung Cancer Than Cigarette Smoke, Study Finds

Lung Cancer, News

E-cigarettes carry much less cancer risk than tobacco smoke, although some types are more risky than others, a study shows. The research, “Comparing the cancer potencies of emissions from vapourised ... Read more

June 27, 2017June 27, 2017

FDA Approves Tafinlar/Mekinist Combo to Treat Specific Type of Lung Cancer

Lung Cancer, News

The U.S. Food and Drug Administration (FDA) approved the combination therapy Tafinlar (dabrafenib) and Mekinist (trametinib) as a treatment for patients with metastatic non-small cell lung cancer (NSCLC) carrying specific ... Read more

June 23, 2017June 23, 2017

Pulmonary Fibrosis Patients May Have Genetic Susceptibility to Lung Cancer, Study Shows

Idiopathic Pulmonary Fibrosis, Lung Cancer, News

Pulmonary fibrosis (PF) patients with lung cancer have alterations in 14 cancer-driver genes, a new French study analyzing cancer samples from PF patients reported. The study is titled, “Morphologic and molecular study of lung ... Read more